Rifaximin Oral

Permitted Indications

Only on the advice of a GI Specialist for:

  1. Reduction in episodes of overt hepatic encephalopathy in patient’s ≥18 years of age who present with persistent symptoms despite being on lactulose, or in those who are lactulose intolerant. Treatment may be initiated in primary care.

Wards Stocked

ARI Ward 104

ARI Ward 201 (Intensive Therapy Unit)